FDA.reportPublic FDA data

aficamten 20 MG Oral Tablet [Myqorzo]

RxCUI
2731492
RxNorm name
aficamten 20 MG Oral Tablet [Myqorzo]
Display name
aficamten 20 MG Oral Tablet [Myqorzo]
Full name
aficamten 20 MG Oral Tablet [Myqorzo]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:29

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MYQORZOAFICAMTENCytokinetics Inc.fd778507-1274-4d1a-a659-5431d55c543a2025-12-16Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2731492

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
fd778507-1274-4d1a-a659-5431d55c543aMyqorzo 20 MG Oral Tablet [PSN] · aficamten 20 MG Oral Tablet [Myqorzo] [SBD] · Myqorzo 20 MG Oral Tablet [SY]32These highlights do not include all the information needed to use MYQORZO safely and effectively. See full prescribing information for MYQORZO. MYQORZO™ (aficamten) tablets, for oral use Initial U.S. Approval: 202520251216